EXCHANGE TRADED CONCEPTS, LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1457320 OKLAHOMA CITY, OK

Position in PTGX

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$2,505,674

-$554,632 QoQ

Shares Held

23,773

-32.2% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EXCHANGE TRADED CONCEPTS, LLC holds $43,501,968 across 34 Biotechnology names. PTGX ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	13,875	$6,195,741
2	REGN	Regeneron Pharmaceuticals, Inc.	5,806	$4,485,946
3	INVA	Innoviva, Inc.	161,248	$3,757,078
4	VKTX	Viking Therapeutics, Inc.	83,569	$2,719,335
5	IONS	Ionis Pharmaceuticals Inc	33,941	$2,548,629
6	PTGX	Protagonist Therapeutics, Inc This page	23,773	$2,505,674
7	HRMY	Harmony Biosciences Holdings, Inc.	87,012	$2,437,205
8	DNA	Ginkgo Bioworks Holdings, Inc.	321,962	$1,973,627

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,505,674	23,773	-32.2%	Shares	Other	2026-04-15
2025-12-31	$3,060,306	35,039	+4.4%	Shares	Other	2026-01-14
2025-09-30	$2,228,859	33,552	-29.2%	Shares	Other	2025-10-14
2025-06-30	$2,619,300	47,391	+73.0%	Shares	Other	2025-07-10
2025-03-31	$1,324,677	27,392	+2572.4%	Shares	Other	2025-04-17
2024-12-31	$39,565	1,025	+6.7%	Shares	Other	2025-01-21
2024-09-30	$43,245	961	—	Shares	Other	2024-10-10
No filing history on record for this holder in this stock.